{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-010536","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2023-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.596590+00:00","generated_at":"2026-06-20T00:48:20.397538+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rigel Pharmaceuticals CMO Wolfgang Dummer resigns, effective March 31, 2023","bullets":["Wolfgang Dummer, EVP and Chief Medical Officer, will resign effective March 31, 2023.","Company has initiated a search for a new CMO with substantial hematology-oncology experience.","Dummer will continue in his role through the separation date and receive severance under the Executive Severance Plan.","Resignation deemed a Non-COC Qualifying Termination; requires full release of claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-010536","json":"https://secwatch.observer/filing/0001104659-23-010536.json","markdown":"https://secwatch.observer/filing/0001104659-23-010536.md","text":"https://secwatch.observer/filing/0001104659-23-010536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000110465923010536/0001104659-23-010536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000110465923010536/tm235424d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T00:48:20.397538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"61ee18154b","claim":"Wolfgang Dummer resigned as Executive Vice President and Chief Medical Officer at RIGEL PHARMACEUTICALS INC.","evidence_excerpt":"Wolfgang Dummer, M.D., Ph.D. informed Rigel Pharmaceuticals, Inc. (the “Company”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Medical Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1034842/000110465923010536/0001104659-23-010536-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}